Psoriatic arthritis
MONDO:0011849Joint inflammation associated with psoriasis.
Also known as: arthritis psoriatica, arthropathic psoriasis, psoriatic arthritis, susceptibility to, psoriatic arthritis, susceptibility to, 1, susceptibility to psoriatic arthritis
240 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a common blood thinner shield psoriasis Patients' arteries?
Disease control Not yet recruitingThis trial tests whether antiplatelet medications, specifically clopidogrel and aspirin, can reduce inflammation in the blood vessels of people with psoriasis or psoriatic arthritis. Participants take each drug or a placebo for four weeks, and researchers measure changes in infla…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New daily pill aims to tame psoriatic arthritis symptoms
Disease control Not yet recruitingThis phase 2 trial tests an experimental oral drug called CBP-0276 in adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin plaques. Participants receive either a low dose (200 mg), a high dose (800 mg), or a placebo daily for 24 weeks. The ma…
Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Experimental drug aims to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early study tests an experimental drug called STR-P005 in people with autoimmune diseases that have come back or not improved with standard treatments. The drug is given through an IV in multiple doses. The main goal is to check safety and see how the body handles the drug. …
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug STR-P005 aims to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early study tests a new drug called STR-P005 in 18 people with autoimmune diseases that have not responded to standard treatments. The main goal is to check safety and find the best dose. Participants receive the drug by infusion in different schedules, and researchers will …
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo aims to tame stubborn psoriatic arthritis
Disease control Not yet recruitingThis study tests whether adding deucravacitinib to standard therapy helps adults with psoriatic arthritis that is not well controlled. About 128 participants will receive the combination and be monitored for 48 weeks. The goal is to reduce skin and joint symptoms and improve qual…
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Head-to-Head: which drug combo tames psoriatic arthritis better?
Disease control Not yet recruitingThis study compares two treatment combinations for adults with psoriatic arthritis who did not get enough relief from methotrexate alone. One group will receive apremilast plus methotrexate, the other adalimumab plus methotrexate. Researchers will measure joint and skin disease a…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could ozempic shield psoriatic arthritis patients from heart disease?
Disease control Not yet recruitingThis study tests whether semaglutide (Ozempic), a drug used for diabetes and weight loss, can slow the buildup of plaque in arteries of people with psoriatic arthritis who do not have diabetes. Forty participants will receive either semaglutide or no additional treatment for 24 w…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New ultrasound technique could spot hidden tendon damage in psoriatic arthritis
Diagnosis Not yet recruitingThis study will test a special ultrasound technique called shear-wave elastography to see if it can better detect tendon inflammation (enthesitis) in people with psoriatic arthritis. Researchers will compare this method with standard ultrasound and also look at how it relates to …
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
AI takes on arthritis: could computers Out-Diagnose doctors?
Diagnosis Not yet recruitingThis study will test whether artificial intelligence can accurately tell the difference between inflammatory arthritis (like rheumatoid arthritis) and degenerative arthritis (like osteoarthritis) in people aged 60 and older. Researchers will compare the AI's analysis of X-rays, M…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 26, 2026 12:51 UTC
-
Could one antibiotic dose before tooth pulling prevent infections in Immune-Weakened patients?
Prevention Not yet recruitingThis study tests whether a single dose of amoxicillin before a simple tooth extraction can prevent infections in people with autoimmune rheumatic diseases who are on immune-suppressing medications. Researchers will compare infection rates between those who get the antibiotic and …
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Yearly TB check may shield vulnerable patients from a hidden threat
Prevention Not yet recruitingThis trial investigates whether annual re-screening for tuberculosis infection using a blood test (IGRA) can prevent active TB in people with autoimmune rheumatic diseases who are taking biologic or immunosuppressive medications. Participants who initially test negative for TB ar…
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Could a simple pill boost knee replacement recovery?
Symptom relief Not yet recruitingThis study tests whether taking tranexamic acid pills for a week after knee replacement surgery helps people recover better. 350 adults having their first knee replacement will receive either the drug or a placebo. Researchers will track pain, stiffness, and function for up to 2 …
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Zapping the brain to ease joint pain: new trial tests TMS for psoriatic arthritis
Symptom relief Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can reduce chronic pain in people with psoriatic arthritis. Researchers will give 40 adults with low disease activity but ongoing pain either real rTMS o…
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Can sound waves boost arthritis shots?
Symptom relief Not yet recruitingThis study tests whether using ultrasound therapy before a steroid injection into the joint can improve pain and swelling for people with arthritis. About 100 adults with arthritis in their arms or legs will receive the combined treatment. The goal is to see if the ultrasound hel…
Phase: NA • Sponsor: Taichung Veterans General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Exercise may be the new prescription for psoriatic arthritis patients
Symptom relief Not yet recruitingThis study tests whether a 12-week program of high-intensity interval training and strength training can improve heart and metabolic health in people with psoriatic arthritis. Researchers will also measure changes in fitness, pain, fatigue, and quality of life. The trial plans to…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can a Self-Image workshop help rheumatic disease patients feel better about themselves?
Symptom relief Not yet recruitingThis study tests a therapeutic education program designed to improve self-image and self-esteem in adults with chronic inflammatory rheumatic diseases like rheumatoid arthritis and spondyloarthritis. Sixty participants will complete questionnaires and interviews before and after …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 26, 2026 15:59 UTC
-
Can a prefilled pen match a syringe for this biosimilar?
Knowledge-focused Not yet recruitingThis study compares two ways of giving the same experimental biosimilar drug, DRL_AB, which is designed to work like abatacept for autoimmune conditions. Healthy male volunteers receive a single dose either through an autoinjector or a prefilled syringe. Researchers measure how m…
Phase: PHASE1 • Sponsor: Dr. Reddy's Laboratories Limited • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New study to measure drug levels in breast milk of moms on TREMFYA
Knowledge-focused Not yet recruitingThis study will measure how much of the drug TREMFYA (guselkumab) passes into breast milk of 10 nursing women who are already taking it for conditions like psoriasis, psoriatic arthritis, ulcerative colitis, or Crohn's disease. Researchers will collect milk samples to estimate th…
Phase: PHASE4 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Blood marker may reveal hidden inflammation in arthritis patients
Knowledge-focused Not yet recruitingThis study will measure a protein called IL-41 in the blood of 90 people with ankylosing spondylitis or psoriatic arthritis, plus healthy volunteers. Researchers want to see if higher levels of this protein are linked to more active disease. The goal is to find a simple blood tes…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Your phone could predict arthritis before it strikes
Knowledge-focused Not yet recruitingThis study tests whether smartphone data and optional smartwatches can detect early signs of psoriatic arthritis in people with psoriasis. About 3,458 adults with psoriasis but no arthritis will use an app that passively collects phone data. The goal is to develop algorithms that…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study tracks psoriatic arthritis treatment success across therapy lines
Knowledge-focused Not yet recruitingThis observational study follows 400 adults with psoriatic arthritis who are starting a new biologic or targeted synthetic drug as part of their routine care. Researchers want to see if treatment response differs based on how many prior advanced therapies a person has tried, and …
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New study eyes Tirzepatide's hidden impact on joints and heart
Knowledge-focused Not yet recruitingThis observational study in Mexico will follow 30 adults already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans of the knees, CT scans of the heart, and body composition tests to see how the drug affects cartilage, heart fat, and overal…
Sponsor: JULIO GRANADOS MONTIEL • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Costa rica psoriasis study reveals hidden heart and joint risks
Knowledge-focused Not yet recruitingThis study will look at the health records of 350 people with psoriasis in Costa Rica to find out how many also have conditions like obesity, diabetes, high blood pressure, heart disease, or psoriatic arthritis. Researchers want to understand how these problems relate to psoriasi…
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Gene clue hunt in back and joint disease
Knowledge-focused Not yet recruitingThis study will measure the activity of a gene called TNFAIP3 in 110 people with ankylosing spondylitis or psoriatic arthritis. The goal is to see if the gene's expression is linked to how active the disease is. Researchers will use a blood test to check gene levels and compare t…
Phase: NA • Sponsor: Asmaa Hassan mohamed Abdel Mawjoud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Arthritis app aims to boost drug safety skills
Knowledge-focused Not yet recruitingThis study tests whether a smartphone app can help people with rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis learn how to use their anti-rheumatic drugs more safely. About 144 adults will either use the app or receive standard care with a website. The goal is to…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Costa rica launches registry to see how new psoriasis drugs work in real life
Knowledge-focused Not yet recruitingThis observational registry will follow 50 patients with psoriasis or psoriatic arthritis who are receiving IL-23 inhibitors (guselkumab or risankizumab) as part of their routine care in Costa Rica. Researchers will track how well the drugs improve skin and joint symptoms and qua…
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can hospitals boost vaccine access for the most vulnerable?
Knowledge-focused Not yet recruitingThis study will test a new way to offer vaccines to vulnerable patients—those with chronic diseases or weakened immune systems—during hospital visits. Researchers will see if offering, prescribing, and giving vaccines in the hospital increases how many people get vaccinated. The …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Can a quick skin scan reveal hidden inflammation in arthritis?
Knowledge-focused Not yet recruitingThis study will measure harmful molecules called AGEs in 300 people with various rheumatic diseases (like rheumatoid arthritis and ankylosing spondylitis) and compare them to healthy volunteers. AGEs build up over time and can cause inflammation. Researchers will use a non-invasi…
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New study tracks how kids with arthritis fare on Long-Term secukinumab
Knowledge-focused Not yet recruitingThis study follows 100 children aged 6 to 17 with juvenile psoriatic or enthesitis-related arthritis who are taking secukinumab. Researchers will observe how doctors adjust treatment after the disease becomes inactive, and whether patients experience flares. The goal is to learn …
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New blood test could spot autoimmune diseases earlier
Knowledge-focused Not yet recruitingThis study will use a special blood test called mass spectrometry to look at immune cells in 500 people with various autoimmune diseases and healthy volunteers. The goal is to find patterns that could help doctors diagnose these conditions sooner. No treatments are being tested; …
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC